Literature DB >> 24020946

Immunohistochemical analysis of extracellular matrix bleb capsules of functioning and non-functioning glaucoma drainage implants.

Juha Välimäki1, Hannu Uusitalo.   

Abstract

PURPOSE: To detect by immunohistochemical means the changes in bleb capsules at the cellular level between functioning and non-functioning glaucoma drainage implants (GDIs).
METHODS: Three samples each of functioning (1 Baerveldt and 2 Molteno implants) and non-functioning filtration blebs (1 Molteno and 2 Ahmed implants) were studied. A non-functioning bleb was defined as an intra-ocular pressure (IOP) >21 mmHg or a <20% reduction in IOP from baseline on three consecutive follow-up visits with maximal tolerated medication. The capsules were obtained between 6 and 108 months after GDI insertion for medical reasons only. Primary antibodies were used to stain fibronectin, tenascin, laminin, collagen IV and smooth muscle actin (SMA). The samples were graded on the basis of the intensity and quantity of immunohistochemical staining into four categories as follows: no staining or a mild, moderate or marked staining.
RESULTS: The non-functioning blebs expressed more fibronectin, tenascin and SMA through the whole capsule wall than the functioning blebs. In the functioning blebs, tenascin was found mainly in the inner layer of the capsule. More type IV collagen and laminin were also found in the non-functioning bleb capsules than in the functioning blebs. No difference was found between the bleb capsules irrespective of whether they had been perfused with aqueous humour immediately after surgery (Ahmed) or after a delay (Molteno, Baerveldt).
CONCLUSION: Accumulation of extracellular matrix components and activated fibroblasts in the bleb capsules of non-functioning GDI indicates the presence of an active wound healing process, suggesting a possible reduction in filtration through the bleb wall.
© 2013 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  collagen IV; fibronectin; glaucoma tube surgery; laminin; smooth muscle actin; tenascin

Mesh:

Substances:

Year:  2013        PMID: 24020946     DOI: 10.1111/aos.12267

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

1.  Absence of lymphatic vessels in non-functioning bleb capsules of glaucoma drainage devices.

Authors:  Robert Siggel; Falk Schroedl; Thomas Dietlein; Konrad R Koch; Christian Platzl; Alexandra Kaser-Eichberger; Claus Cursiefen; Ludwig M Heindl
Journal:  Histol Histopathol       Date:  2020-12-31       Impact factor: 2.303

2.  A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration.

Authors:  Ian Grierson; Don Minckler; Marian K Rippy; Andrew J Marshall; Nathalie Collignon; Jessica Bianco; Benoit Detry; Murray A Johnstone
Journal:  BMC Biomed Eng       Date:  2020-10-14

3.  Altered expression of fibrosis genes in capsules of failed Ahmed glaucoma valve implants.

Authors:  Alka Mahale; Maha W Othman; Sami Al Shahwan; Ibrahim Al Jadaan; Ohood Owaydha; Zahid Khan; Deepak P Edward
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

4.  Histopathologic and immunohistochemical features of capsular tissue around failed Ahmed glaucoma valves.

Authors:  Alka Mahale; Fatma Fikri; Khitam Al Hati; Sami Al Shahwan; Ibrahim Al Jadaan; Hind Al Katan; Rajiv Khandekar; Azza Maktabi; Deepak P Edward
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

5.  Comparison of Six Different Silicones In Vitro for Application as Glaucoma Drainage Device.

Authors:  Claudia Windhövel; Lisa Harder; Jan-Peter Bach; Michael Teske; Niels Grabow; Thomas Eickner; Ulf Hinze; Boris Chichkov; Ingo Nolte
Journal:  Materials (Basel)       Date:  2018-02-27       Impact factor: 3.623

6.  Factors associated with the surgical outcomes of Baerveldt glaucoma implant for open-angle glaucoma, an age-related eye disease.

Authors:  Satoshi Iraha; Yuji Takihara; Yui Urahashi; Takahiro Watanabe; Kenichi Nakamura; Mai Urahashi; Fumika Watanabe-Kitamura; Kei-Ichi Nakashima; Eri Takahashi; Sachi Kojima; Hidenobu Tanihara; Toshihiro Inoue
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.